Pravastatin SLCO1B1 PGx Model
Indication: Hypercholesterolemia
Interactive pravastatin pharmacokinetics simulator with enterohepatic circulation model and SLCO1B1 pharmacogenomic effects. Explore how genetic variants affect drug exposure.
Drug Overview
Clinical Context
- Drug Class
- Statin
- Therapeutic Area
- Cardiology
- Indication
- Hypercholesterolemia
- Route of Administration
- oral
Model Information
- Model Type
- EHC model with Erlang absorption + SLCO1B1 pharmacogenomics
- Category
- PopPK
- Reference
- Ide et al. J Clin Pharmacol 2009;49:1309-1317
This simulator was built from published pharmacometric literature using PKPDBuilder's AI-powered model extraction pipeline.
Pharmacokinetic Parameters
PK Parameters
| Parameter | Value |
|---|---|
| CL F | 139 L/h |
Additional Parameters
| Parameter | Value |
|---|---|
| tg | 3.61 h |
| K12 | 0.183 h⁻¹ |
| K21 | 0.436 h⁻¹ |
| MTT | 0.660 h |
| V1 F | 253 L |
Parameters sourced from published population pharmacokinetic models. Values represent typical population estimates; individual patient parameters may vary.
About This Simulator
This interactive pharmacokinetic simulator for Pravastatin SLCO1B1 PGx Model allows you to explore concentration-time profiles under different dosing scenarios. The underlying PopPK model characterizes the pharmacokinetics of this statin following oral administration.
Use the simulator to visualize key exposure metrics including AUC (area under the curve), Cmax (peak concentration), and Ctrough (trough concentration).
Built with PKPDBuilder — an AI-powered platform that transforms published pharmacometric literature into interactive, deployable Shiny applications. No coding required.
Frequently Asked Questions
What is the Pravastatin SLCO1B1 PGx Model PK simulator?
This is a free, interactive pharmacokinetic simulator for Pravastatin SLCO1B1 PGx Model used in Hypercholesterolemia. It allows researchers, pharmacologists, and students to explore concentration-time profiles, dosing regimens, and exposure metrics based on published population PK models.
What drug class does Pravastatin SLCO1B1 PGx Model belong to?
Pravastatin SLCO1B1 PGx Model is classified as a Statin. It is used in the Cardiology therapeutic area.
What route of administration does this model simulate?
This simulator models oral administration of Pravastatin SLCO1B1 PGx Model. The pharmacokinetic parameters (absorption rate, bioavailability, volume of distribution) are specific to this route.
What type of PK model is used?
This simulator uses a PopPK model. Population PK models account for interindividual variability and covariate effects on drug exposure.
Is this simulator free to use?
Yes, all PKPDBuilder simulators are completely free. They are built from published pharmacokinetic literature and are intended for research and educational purposes. No login is required to run simulations.
Can I use this for clinical dosing decisions?
No. This simulator is for research and educational purposes only. It should not be used for clinical decision-making or patient dosing. Always consult the prescribing information and clinical pharmacology guidelines for therapeutic drug use.
What is the clearance of Pravastatin SLCO1B1 PGx Model?
The clearance (CL) of Pravastatin SLCO1B1 PGx Model is approximately 139 L/h. Clearance represents the volume of plasma from which drug is completely removed per unit time and is a key determinant of drug exposure and steady-state concentrations.
Related Simulators
Xarelto (Rivaroxaban) PK Simulator
Stroke prevention in atrial fibrillation
Vyndaqel (Tafamidis) PK Simulator
Transthyretin amyloid cardiomyopathy
Entresto (Sacubitril/Valsartan) PK Simulator
Heart failure with reduced ejection fraction
Eliquis (Apixaban) PK Simulator
Stroke prevention in atrial fibrillation
Simvastatin PK Simulator
Hypercholesterolemia
Pravastatin EHC Model
Hypercholesterolemia
Ready to Simulate?
Launch the Pravastatin SLCO1B1 PGx Model simulator to explore dosing scenarios and pharmacokinetic profiles interactively.
🚀 Launch SimulatorComments
⚠️ Disclaimer
This simulator is for research and educational purposes only. It is not intended for clinical decision-making, patient dosing, or therapeutic drug monitoring. Pharmacokinetic parameters are derived from published literature and represent population-level estimates. Individual patient pharmacokinetics may differ significantly. Always consult approved prescribing information and qualified healthcare professionals for clinical decisions.
Powered by PKPDBuilder.com • Free pharmacokinetic simulators for the scientific community